Haugan, Anne-Lise Juul
Sund, Anne Mari
Young, Susan
Thomsen, Per Hove
Lydersen, Stian
Nøvik, Torunn Stene
Funding for this research was provided by:
NTNU Norwegian University of Science and Technology
Article History
Received: 15 November 2021
Accepted: 25 May 2022
First Online: 2 June 2022
Change Date: 27 August 2022
Change Type: Update
Change Details: The OA funding note has been added. The article has been updated to rectify the error.
Declarations
:
: Written informed consent was obtained from adolescents and parents before enrolment into the study (parents signed the forms for participants under 16 years). In the case of dropouts, the participants were asked to consent to the use of the baseline data. The study was approved by the Regional Committee for Medical and Health Research Ethics in Southeast Norway (2015/2115). The study was conducted according to the principles set forth in the Declaration of Helsinki from 1964 and later amendments. The study was also performed and reported according to CONSORT guidelines [CitationRef removed] (see checklist in supplemental material).
: Not applicable.
: PHT has received speaker’s fees from Medice and Shire in the last three years. TSN has received a speaker’s fee from Medice during the last three years. SY has received honoraria for consultation and/or educational talks in the last 5 years from Janssen, HB Pharma, Shire and Medice. AMS has received travel support and a congress fee from Medice in the last three years. AJH has received travel support and a speaker’s fee from Medice in the last year, SL declares no conflicts of interest.